
Join Sue Stevenson in #InOurWords as she talks about Novartis' positioning in cell and gene therapy. And how infrastructure, commitment and manufacturing capabilities are critical to advancing the field. #livemagazine #novartis #science #research


One patient - one story. More than 1.5 million people suffer from chronic myeloid leukaemia. #livemagazine #novartis #science #research

Listen to #InOurWords with Sue Stevenson about why it's possible to get to the root of the disease with cell and gene therapy, and its potential to make a lasting difference in patients' lives without the need for daily pills. #livemagazine #novartis #science #research
